Acumen Research and Consulting, Recently Published Report On “Elastography Imaging Market Size, Share, Trends, Growth Opportunity and Forecast 2019-2026”.
LOS ANGELES, July 09, 2019 (GLOBE NEWSWIRE) -- The global elastography imaging market size is estimated to grow at CAGR above 7.4 % over the forecast time frame 2019 to 2026 and reach the market value around USD 3.2 billion by 2026.
Increased breast cancer and chronic liver diseases are anticipated to drive the market considerably. Furthermore, increased demand for minimally invasive processes and continuing research for the evaluation of prospective uses of elastography will lead to fast development.
Free Download Sample Report Pages for Better understanding@ https://www.acumenresearchandconsulting.com/request-sample/1501
Elastography currently has extensive apps for breasts, thyroid, prostate and liver evaluation. More and more on-going studies are anticipated to enhance their applications when diagnosing different circumstances such as chronic kidneys and neurodegenerative disorders. The findings for their use in kidney health assessments during and after transplantation have been promising.
In 2018, North America dominated the market, and its domination over the forecast period is anticipated to proceed. The elastography market growth observed in the region is due, along with elevated adoption rates for sophisticated imaging methods, to the existence of a big amount of worldwide actors.
In the forecast period, increasing strategic alliances between players for product development and distribution will drive the market. Furthermore it will improve the implementation of sophisticated imaging technologies in the creation of fresh surgical facilities in various places.
View Detail Information with Complete TOC@ https://www.acumenresearchandconsulting.com/elastography-imaging-market
Elastography is a method used for medical imaging for the measurement of elastic characteristics and rigidity of soft tissue. The most popular method in the elastography of a stiffness map, the determination of several illnesses of the body is ultrasound and magnetic resonance imaging. Biopsy occurs as a totally noninvasive method in elastography imaging. The elastographic imaging of multiple cancers, like breast, thyroid and prostate cancer, is used. The diagnosis of liver disease is mostly based on the elastography imaging. In musculoskeletal imaging the specific form of elastographical imaging is used to define mechanical features and muscle and tendon conditions.
Key Findings
By modality, important growth is expected for the ultrasound segment during the forecasting era due to benefits like low cost, accessibility and a high level of tissue deformation measurement.
Due to its increasing amount of ultrasounds and MRIs, the hospital segment is expected to have the biggest market share during the projected time span on the grounds of end use.
The radiology domain is expected to play a big part in the industry over the forecast era due to an increasing demand for image-led radiotherapy and radiological ultrasounds by means of implementation.
Asia Pacific is projected to see profitable development during the prediction era because healthcare facilities are being improved and geriatric populations increasingly susceptible to targeted illnesses.
Browse all official Market Research Reports Press Releases@ https://www.acumenresearchandconsulting.com/press-releases
Explore Our Market Blog@ https://www.acumenresearchandconsulting.com/blogs
Key Players & Strategies
The leading players profiling on the market are Medison Co., Ltd.; Canon Medical Systems Corporation; Fujifilm Corporation ; Esaote SpA ; GE Healthcare; Koninklijke Philips N.V. ; Hitachi, Ltd. ; Mindray Bio-Medical Electronics Co., Ltd.
Key players focus on strategic alliances through partnerships or partnerships to create fresh concepts and grow their product portfolio. GE Healthcare has lately extended its partnership with SonoSim, for example. This cooperation aims to improve the ultrasound education of its customers.
The companies focus on the launch of a fresh product to promote elastography imagery, which is supposed to promote the development of the industry. Manufacturers concentrate on clinical trials and market expansion FDA approvals. Phillips ElastQ Imaging (shear wave elastography) capacity for the picture of the tissue was approved by FDA in February 2017. The increasing amount of hepatitis B diseases, liver cancer, is anticipated to contribute to the development of the industry in elastography and imaging. In the biopsy phase, elastographic imaging instruments become popular as advantages of non-invasive processes. The increased incidence of different cancers is anticipated to support the demand for elastographic imagery equipment. Increasing use of low invasive processes promotes the development of the market for elastographic imagery. The demand of brain tissue imaging as a noninvasive operation is increasing in magnetic resonance elastography.
Acumen Research and Consulting Enters Partnership with MARKETWATCH, Click Here
Request for Customization@ https://www.acumenresearchandconsulting.com/request-customization/1501
The report is readily available and can be dispatched immediately after payment confirmation.
Buy this premium research report - https://www.acumenresearchandconsulting.com/buy-now/0/1501
If you would like to place an order or have any questions, please feel free to contact at sales@acumenresearchandconsulting.com | +1 407 915 4157
For Latest Update Follow Us:
https://www.facebook.com/acumenresearchandconsulting
https://www.linkedin.com/company/acumen-research-and-consulting/